On November 13, DUALITYBIO-B fell 4.05% in Regular Trading to HK$104.3, with turnover of HK$26.90 million.
The most recent market update tied sentiment to continued on-market share purchases by Chairman Zhu Zhongyuan and company buybacks, but indicated that those supportive signals had limited effect on the day’s price action as the stock retreated toward the chairman’s recent accumulation range.
Background disclosures show Zhu bought 10,000 shares on November 10 at an average HK$107.276, lifting his stake to 17.66%. Before that, he made a series of on-market purchases from October 30 to November 6, while the company also repurchased shares on November 2, 3, 5 and 6. Together with the previously announced voluntary lock-up by directors and senior management, these steps signaled confidence in long-term value, but did not prevent the current intraday weakness.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments